Cytek Biosciences Inc.
(CTKB)
undefined
undefined%
At close: undefined
6.21
0.32%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -12.15M | 2.48M | 3.03M | 19.41M | -16.83M |
| Depreciation & Amortization | 9.23M | 5.66M | 1.24M | 603.00K | 309.00K |
| Stock-Based Compensation | 22.05M | 16.59M | 6.59M | 611.00K | 269.00K |
| Other Working Capital | -5.68M | -4.39M | 11.04M | -2.11M | 27.17M |
| Other Non-Cash Items | -3.34M | 2.96M | 1.97M | 323.00K | 1.34M |
| Deferred Income Tax | - | - | 448.00K | 1.74M | - |
| Change in Working Capital | -10.51M | -39.93M | -8.65M | -7.54M | 1.16M |
| Operating Cash Flow | 5.28M | -12.23M | 4.63M | 15.16M | -13.75M |
| Capital Expenditures | -4.83M | -9.87M | -4.36M | -1.55M | -973.00K |
| Acquisitions | -45.13M | - | -16.63M | - | - |
| Purchase of Investments | -175.94M | -46.04M | - | - | - |
| Sales Maturities Of Investments | 132.00M | - | - | - | - |
| Other Investing Acitivies | -179.00K | -46.16M | 371.00K | - | - |
| Investing Cash Flow | -93.89M | -55.91M | -20.99M | -1.55M | -973.00K |
| Debt Repayment | -565.00K | 2.93M | - | 2.77M | - |
| Common Stock Repurchased | -44.15M | -209.00K | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | 2.90M | 2.58M | 213.56M | 239.50M | 93.00K |
| Financial Cash Flow | -41.81M | 5.51M | 213.56M | 122.61M | 93.00K |
| Net Cash Flow | -131.87M | -65.12M | 198.50M | 135.63M | -14.66M |
| Free Cash Flow | 454.00K | -22.10M | 266.00K | 13.61M | -14.72M |